Paraneoplastic syndromes: an approach to diagnosis and treatment.
Recent medical advances have improved the understanding, diagnosis, and treatment of paraneoplastic syndromes. These disorders arise from tumor secretion of hormones, peptides, or cytokines or from immune cross-reactivity between malignant and normal tissues. Paraneoplastic syndromes may affect diverse organ systems, most notably the endocrine, neurologic, dermatologic, rheumatologic, and hematologic systems. The most commonly associated malignancies include small cell lung cancer, breast cancer, gynecologic tumors, and hematologic malignancies. In some instances, the timely diagnosis of these conditions may lead to detection of an otherwise clinically occult tumor at an early and highly treatable stage. Because paraneoplastic syndromes often cause considerable morbidity, effective treatment can improve patient quality of life, enhance the delivery of cancer therapy, and prolong survival. Treatments include addressing the underlying malignancy, immunosuppression (for neurologic, dermatologic, and rheumatologic paraneoplastic syndromes), and correction of electrolyte and hormonal derangements (for endocrine paraneoplastic syndromes). This review focuses on the diagnosis and treatment of paraneoplastic syndromes, with emphasis on those most frequently encountered clinically. Initial literature searches for this review were conducted using PubMed and the keyword paraneoplastic in conjunction with keywords such as malignancy, SIADH, and limbic encephalitis, depending on the particular topic. Date limitations typically were not used, but preference was given to recent articles when possible.
Pelosof
Lorraine C
LC
Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390-8852, USA.
Gerber
David E
DE
D003480:Cushing Syndrome / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D006934:Hypercalcemia / Q000175:diagnosis / Q000628:therapy; D007003:Hypoglycemia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D007177:Inappropriate ADH Syndrome / Q000175:diagnosis / Q000628:therapy; D020364:Paraneoplastic Polyneuropathy / Q000175:diagnosis / Q000628:therapy; D010257:Paraneoplastic Syndromes / Q000097:blood / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D044162:Parathyroid Hormone-Related Protein / Q000378:metabolism
D044162:Parathyroid Hormone-Related Protein
Blood. 1993 Oct 1;82(7):2261-2
8400277
Neurology. 1996 Sep;47(3):678-83
8797464
J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):270-8
8795598
Blood. 1996 Jun 1;87(11):4831-8
8639856
Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13254-9
9789075
Cell. 1991 Oct 18;67(2):325-33
1655278
Br J Dermatol. 1999 Mar;140(3):565-6
10233302
N Engl J Med. 1999 Jan 21;340(3):227-8
9895405
Cancer Res. 2000 Apr 15;60(8):2136-9
10786675
Eur J Endocrinol. 2009 Jun;160(6):1003-10
19289534
Arch Neurol. 1999 Feb;56(2):172-7
10025422
J Neurol Neurosurg Psychiatry. 2004 Aug;75(8):1135-40
15258215
Ann Neurol. 2001 Feb;49(2):214-21
11220741
Brain. 2003 Jun;126(Pt 6):1409-18
12764061
Pharmacotherapy. 2007 Nov;27(11):1529-49
17963462
Crit Rev Oncol Hematol. 2008 Feb;65(2):172-82
17950613
Acta Haematol. 2003;109(4):202-5
12853695
Am J Hematol. 2008 Jun;83(6):491-7
18429051
Genes Dev. 1999 Aug 15;13(16):2087-97
10465786
N Engl J Med. 2005 Jan 27;352(4):373-9
15673803
Leukemia. 1989 Jan;3(1):14-8
2642572
Emerg Med Clin North Am. 2009 May;27(2):257-69
19447310
J Neuroimmunol. 2008 May 30;196(1-2):166-9
18455243
Leuk Lymphoma. 2007 May;48(5):855-65
17487727
Int J Hematol. 2009 Dec;90(5):597-600
19760482
J Neurol. 2005 May;252 Suppl 1:I14-8
15959667
Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):63-9
9459574
Br J Dermatol. 1999 Oct;141(4):714-6
10583123
Muscle Nerve. 1997 Sep;20(9):1146-52
9270671
Cancer. 1996 Nov 15;78(10):2153-6
8918408
Am J Med. 2007 Oct;120(10):841-7
17904451
J Nephrol. 2006 Mar-Apr;19(2):220-1
16736425
J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):479-82
10727484
Arch Dermatol. 2002 Jul;138(7):885-90
12071815
J Am Acad Dermatol. 1994 May;30(5 Pt 1):752-7
8176015
Neurology. 2003 Dec 23;61(12):1652-61
14694025
Br J Dermatol. 2010 Feb 1;162(2):337-44
19845665
Muscle Nerve. 1986 Jul-Aug;9(6):523-30
3016532
Ann Rheum Dis. 1993 Dec;52(12):857-61
8311535
Curr Med Chem. 2008;15(4):415-21
18288996
South Med J. 2009 Mar;102(3):334-5
19204636
J Clin Oncol. 1997 Aug;15(8):2866-72
9256130
Blood. 2001 Nov 15;98(10):3136-42
11698302
Eur J Neurol. 2006 Jul;13(7):691-9
16834699
Int J Dermatol. 2009 Mar;48(3):324-6
19261028
Am J Clin Oncol. 2009 Aug;32(4 Suppl):S3-7
19654481
J Immunol. 2007 Oct 15;179(8):5571-5
17911644
Lancet Neurol. 2008 Apr;7(4):327-40
18339348
Clin Nucl Med. 2009 Mar;34(3):155-7
19352278
Proc Natl Acad Sci U S A. 1989 Apr;86(8):2873-7
2649898
J Rheumatol. 2008 Feb;35(2):294-304
18085729
Clin Auton Res. 2009 Feb;19(1):13-9
18726055
Hematol Oncol Clin North Am. 2009 Apr;23(2):249-59
19327582
Am Heart J. 2003 Jul;146(1):9-18
12851603
Ann Neurol. 2000 Jan;47(1):9-17
10632096
N Engl J Med. 1989 Dec 7;321(23):1567-71
2555713
J Thorac Oncol. 2009 Feb;4(2):260-2
19179906
Proc Natl Acad Sci U S A. 1990 Jun;87(11):4149-53
2349224
Thyroid. 2005 Jun;15(6):618-23
16029131
Neurology. 2002 Sep 10;59(5):764-6
12221175
Arch Intern Med. 2009 Nov 9;169(20):1839-50
19901135
Am J Med. 1994 Oct;97(4):374-8
7942941
J Surg Oncol. 2005 Mar 15;89(4):273-5
15726608
Blood. 2001 Aug 15;98(4):1095-9
11493456
N Engl J Med. 1977 Nov 24;297(21):1134-40
917042
Endocrinology. 2007 Jan;148(1):81-91
17053028
Gynecol Oncol. 2002 Feb;84(2):332-4
11812096
Pituitary. 2002;5(2):77-82
12675504
Support Care Cancer. 2007 Dec;15(12):1341-7
17701059
Korean J Intern Med. 2005 Sep;20(3):247-50
16295785
Ann Intern Med. 1978 Aug;89(2):167-72
677578
J Cancer Res Clin Oncol. 2009 Dec;135(12):1783-90
19551407
Dermatologica. 1980;160(5):341-7
7364144
QJM. 2000 Nov;93(11):751-5
11077032
Ann N Y Acad Sci. 2008;1132:305-14
18567882
Semin Thromb Hemost. 2004 Feb;30(1):95-108
15034801
J Neurol Neurosurg Psychiatry. 2007 Mar;78(3):324-5
17308294
Indian J Dermatol Venereol Leprol. 2009 Jul-Aug;75(4):356-62
19584459
Br J Haematol. 2006 Jun;133(5):468-92
16681635
Neurology. 1998 Jun;50(6):1778-83
9633727
Am J Gastroenterol. 2008 Apr;103(4):1052-4
18397441
Orphanet J Rare Dis. 2007 Jul 26;2:34
17655751
Muscle Nerve. 1997 Dec;20(12):1576-82
9390671
Clin Endocrinol (Oxf). 2008 Jun;68(6):904-11
18031316
Br J Haematol. 1985 Jun;60(2):315-22
2408658
N Engl J Med. 1999 Jun 10;340(23):1788-95
10362822
Muscle Nerve. 2010 Feb;41(2):212-8
19816912
Neuro Oncol. 2004 Jan;6(1):55-62
14769141
Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3451-4
2014264
Br J Dermatol. 1981 Oct;105(4):483
7295564
Clin Neurophysiol. 2005 May;116(5):1167-71
15826858
Lancet. 2003 Sep 20;362(9388):971-82
14511932
J Clin Rheumatol. 2007 Apr;13(2):114
17414547
Am J Gastroenterol. 2003 Mar;98(3):708-9
12650823
Orphanet J Rare Dis. 2007 May 04;2:22
17480225
Eur J Haematol. 2003 May;70(5):319-21
12694169
J Neurol. 2006 Jan;253(1):16-20
16444604
Clin Pharmacol Ther. 2009 Jul;86(1):44-8
19357643
Neurology. 2003 Jan 28;60(2):230-4
12552036
J Neurosci. 2001 Sep 15;21(18):7203-14
11549731
J Am Soc Nephrol. 2004 Feb;15(2):398-406
14747386
Am J Clin Dermatol. 2008;9(2):71-92
18284262
Muscle Nerve. 1997 Sep;20(9):1102-7
9270664
Semin Thorac Cardiovasc Surg. 2006 Fall;18(3):191-8
17185178
Br J Dermatol. 2000 Mar;142(3):506-8
10735959
J Neurophysiol. 2003 Sep;90(3):2053-9
12773498
J Med Lyon. 1949 Mar 5;30(700):197-207
18115298
J Clin Endocrinol Metab. 1999 May;84(5):1758-9
10323413
Ann Neurol. 2001 Sep;50(3):339-48
11558790
Neuron. 1993 Oct;11(4):657-72
8398153
Neurology. 2000 Feb 8;54(3):603-7
10680790
Indian J Cancer. 2009 Apr-Jun;46(2):173-4
19346655
J Neuroimmunol. 2001 Sep 3;119(1):10-5
11525795
J Pathol. 2004 Jun;203(2):721-8
15141388
Neuro Oncol. 2007 Jan;9(1):75-7
17018696
J Cancer Res Clin Oncol. 1986;111(1):54-8
3949851
Curr Opin Oncol. 2009 Nov;21(6):566-72
19620862
Neurology. 1984 Apr;34(4):480-5
6322050
Mayo Clin Proc. 2010 Feb;85(2):158-64
20053713
N Engl J Med. 2007 May 17;356(20):2064-72
17507705
Muscle Nerve. 2010 Mar;41(3):375-8
19852027
Brain. 2009 Jul;132(Pt 7):1723-33
19506068
BJU Int. 2008 Feb;101(4):424-7
18070179
Science. 2001 Jan 19;291(5503):484-6
11161202
Int J Dermatol. 2008 Apr;47(4):359-62
18377598
J Pak Med Assoc. 2009 Apr;59(4):253-4
19402293
Arch Neurol. 2010 Mar;67(3):322-9
20065123
Crit Rev Oncol Hematol. 2006 Apr;58(1):79-89
16337807
Oncologist. 2006 Mar;11(3):292-305
16549814
Brain. 2004 Aug;127(Pt 8):1831-44
15215214
Acta Reumatol Port. 2007 Apr-Jun;32(2):181-3
17572653
Am J Med. 1994 Mar;96(3):247-53
8154513
Acta Neuropathol. 1998 Jul;96(1):1-7
9678507
N Engl J Med. 2006 Oct 26;355(17):1772-9
17065638
Am J Hematol. 2000 Feb;63(2):105-6
10629583
Curr Opin Neurol. 2002 Oct;15(5):605-9
12352004
J Clin Rheumatol. 2006 Aug;12(4):199-200
16891926
Liver Int. 2007 Jun;27(5):716-21
17498259
J Thorac Oncol. 2007 Apr;2(4):263-4
17409794
N Engl J Med. 1992 Feb 6;326(6):363-7
1729618
Lancet Neurol. 2008 Dec;7(12):1091-8
18851928
Cancer. 1998 Apr 15;82(8):1585-92
9554538
Eur Arch Otorhinolaryngol. 2006 Jan;263(1):32-6
15986184
J Pharmacol Exp Ther. 1998 Dec;287(3):860-7
9864265
Clin Exp Immunol. 1983 Sep;53(3):697-702
6193913
J Neurol Sci. 1997 Mar 20;147(1):35-42
9094058
Arch Dermatol. 2001 Mar;137(3):269-72
11255323
Blood Rev. 2009 Jul;23(4):157-65
19246139
Chest. 1977 Jun;71(6):789-91
862454
CA Cancer J Clin. 2009 Mar-Apr;59(2):73-98
19258446
Nat Clin Pract Rheumatol. 2006 Aug;2(8):452-6; quiz following 456
16932737
J Neurol. 2008 Jul;255(7):1100-1
18574619
Neurology. 2003 Nov 25;61(10):1438-40
14638974
Cancer. 2009 Sep 1;115(17):3919-23
19551882
Cancer. 1987 Aug 15;60(4):903-5
3036338
Eur J Haematol. 2004 Feb;72(2):79-88
14962245
Ann Intern Med. 1990 Apr 1;112(7):499-504
2138442
Ann Neurol. 2009 Apr;65(4):424-34
19338055
Clin Endocrinol (Oxf). 1998 Oct;49(4):491-8
9876347
Blood. 1984 Feb;63(2):277-86
6581839
Arch Intern Med. 1994 Sep 12;154(17):1985-7
8074604